1996
DOI: 10.1016/s0140-6736(05)64757-5
|View full text |Cite
|
Sign up to set email alerts
|

Hydroxyurea for treatment of unresectable meningiomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0
1

Year Published

2001
2001
2013
2013

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(22 citation statements)
references
References 3 publications
0
21
0
1
Order By: Relevance
“…HU is used to treat hematological malignancies and also to inhibit the growth of tumor cells from other entities (Schrell et al, 1996;Bug et al, 2005;Kra¨mer et al, 2008). We found that a therapeutically achievable dose of HU (Bug et al, 2005) stalled up to 70% of MCF7 cells in S-phase without notable signs of excessive cell death.…”
Section: Resultsmentioning
confidence: 87%
“…HU is used to treat hematological malignancies and also to inhibit the growth of tumor cells from other entities (Schrell et al, 1996;Bug et al, 2005;Kra¨mer et al, 2008). We found that a therapeutically achievable dose of HU (Bug et al, 2005) stalled up to 70% of MCF7 cells in S-phase without notable signs of excessive cell death.…”
Section: Resultsmentioning
confidence: 87%
“…The risk of meningioma formation increases, and the latency period between exposure and tumor development decreases, with higher doses of radiation; however, exposure to even low radiation doses has been shown to significantly increase the risk of meningioma. 53,62,[69][70][71][72] The Israeli experience has shown that even low-dose radiation in children leads to a high and significant increase in the risk of developing meningioma. This risk should be considered when decisions are made to use radiation in routine imaging examinations, such as CT scanning, 10 or to administer higher doses of radiation for treatment of benign tumors during childhood, adolescence, and young adulthood.…”
Section: Discussionmentioning
confidence: 99%
“…Systemic treatment with tamoxifen 21 and hydroxyurea 35,[47][48][49]58,68,69 has been attempted as an adjuvant therapy in patients with recurrent, unresectable SMs. In the past, we have used both of these agents in selected RIM patients with recurrent tumors when surgery and radiotherapy failed, with no measureable response.…”
Section: Other Therapiesmentioning
confidence: 99%
“…O quimioterápico hidroxiuréia administrado oralmente parece ter certo grau de resposta em adultos. Em alguns estudos, hidroxiuréia tem sido usada concomitantemente à radioterapia 22 .…”
Section: Discussionunclassified